Medigrow holds an Operator's License in terms of the Lesotho Drugs of Abuse Act, No.3 of 2008, and is licensed to process and export medical cannabis. Lesotho's natural environment is well suited to growing high-quality medical cannabis. The Government of Lesotho is committed to ensuring cultivation is done in a controlled and responsible manner. They further commit to ensuring no harm and no diversion of medical cannabis production into the illicit market. Medigrow has the expertise to meet the highest quality standards and is committed to local economic development and sustainable job creation. The Company is very supportive of effective local and international regulations that ensure medical cannabis is well regulated and through which its product can be made available to patients in need and improve quality of life.
| Website | http://www.medigrow.com |
| Revenue | $5 million |
| Employees | View employees |
| Industry | Chemicals, Petrochemicals, Glass & Gases, Manufacturing |
| Competitors | Siemens Healthineers, Medtronic, Thermo Fisher Scientific, Abbott, Stryker, Cardinal Health, Boston Scientific, Baxter International Inc., Fresenius Kabi, Johnson & Johnson MedTech Germany +42 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Medigrow Lesotho employee's phone or email?
Medigrow Lesotho Questions
The Medigrow Lesotho annual revenue was $5 million in 2026.
The NAICS codes for Medigrow Lesotho are [541, 54].
The SIC codes for Medigrow Lesotho are [87, 873].
